{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:00:40Z","timestamp":1791576040824,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mcna.2006.10.011","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:20Z","timestamp":1168439300000},"page":"97-111","source":"Crossref","is-referenced-by-count":22,"title":["Nonopioid Analgesics"],"prefix":"10.1016","volume":"91","author":[{"given":"Muhammad A.","family":"Munir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr","family":"Enany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2006.10.011_bib1","series-title":"Acute pain management: operative or medical procedures and trauma: clinical practice guidelines","author":"Acute Pain Management Guideline Panel","year":"1992"},{"key":"10.1016\/j.mcna.2006.10.011_bib2","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(99)03313-9","article-title":"Acute pain","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2006.10.011_bib3","series-title":"The management of pain","first-page":"111","article-title":"Nonopioid and opioid analgesics","author":"Zuckerman","year":"1998"},{"key":"10.1016\/j.mcna.2006.10.011_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3959(94)90045-0","article-title":"Non-steroidal anti-inflammatory drugs and spinal nociceptive processing","volume":"59","author":"McCormack","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.mcna.2006.10.011_bib5","first-page":"231","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"234","author":"Vane","year":"1971","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2006.10.011_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1381521","article-title":"Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition","volume":"257","author":"Malmberg","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.mcna.2006.10.011_bib7","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mcna.2006.10.011_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1136\/bmj.325.7365.619","article-title":"Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials","volume":"325","author":"Deeks","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2006.10.011_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","volume":"4","author":"Rostom","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2006.10.011_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (cox)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mcna.2006.10.011_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(24)38195-9","article-title":"Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids","volume":"289","author":"Catella-Lawson","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mcna.2006.10.011_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nrd1225","article-title":"COX-2 and beyond: approaches to prostaglandin inhibition in human disease","volume":"2","author":"FitzGerald","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.mcna.2006.10.011_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.10.011_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.10.011_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2006.10.011_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.CIR.0000025261.58465.62","article-title":"Cyclooxygenase-2 inhibition and cardiovascular events","volume":"106","author":"Pitt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2006.10.011_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/01.HYP.0000116221.27079.ea","article-title":"Cyclooxygenases, the kidney, and hypertension","volume":"43","author":"Cheng","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2006.10.011_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","article-title":"The clinical significance of inhibition of renal prostaglandin synthesis","volume":"32","author":"Patrono","year":"1987","journal-title":"Kidney Int"},{"key":"10.1016\/j.mcna.2006.10.011_bib19","first-page":"9","article-title":"Primary drug therapy: aspirin vs. the nonsteroidal anti-inflammatory drugs","volume":"May Spec","author":"Ehrlich","year":"1983","journal-title":"Postgrad Med"},{"issue":"8","key":"10.1016\/j.mcna.2006.10.011_bib20","first-page":"547","article-title":"Choline magnesium trisalicylate does not impair platelet aggregation","volume":"2","author":"Stuart","year":"1981","journal-title":"Pharmatherapeutica"},{"key":"10.1016\/j.mcna.2006.10.011_bib21","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.272.23.1845","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2006.10.011_bib22","unstructured":"Food and Drug Administration. Over-the-counter drug products containing analgesic\/antipyretic active ingredients for internal use; required alcohol warning; final rule; compliance date. Food and Drug Administration, HHS, Fed Regist 1999;64(51):13066\u20137."},{"key":"10.1016\/j.mcna.2006.10.011_bib23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.279.9.657","article-title":"Acetaminophen and other risk factors for excessive warfarin anticoagulation","volume":"279","author":"Hylek","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2006.10.011_bib24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0022-3565(24)34895-5","article-title":"Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects","volume":"290","author":"Panara","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mcna.2006.10.011_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/rheumatology\/35.suppl_1.61","article-title":"A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers","volume":"35","author":"Patoia","year":"1996","journal-title":"B Brit J Rheumatol"},{"key":"10.1016\/j.mcna.2006.10.011_bib26","first-page":"1705","article-title":"Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"271","author":"Patrignani","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mcna.2006.10.011_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1365-2036.2000.00715.x","article-title":"Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety","volume":"14","author":"Scott","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.mcna.2006.10.011_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.0000155081.76164.17","article-title":"Parecoxib, valdecoxib and cardiovascular risk","volume":"111","author":"Furberg","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2006.10.011_bib29","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMp048288","article-title":"Coxibs and cardiovascular disease","volume":"351","author":"FitzGerald","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506001179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712506001179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T22:04:54Z","timestamp":1736719494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712506001179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0025712506001179"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2006.10.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}